Anika Therapeutics Inc

Biotech Stocks Healthcare Stocks

$21.49

+0.32 (+1.51%)

As of Aug 15, 2:12 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +11.6% upside

Low Target $18.55

Average Target $23.98

High Target $27.85

Current Price $21.49

Current
$21.49

Target
$23.98

$18.55 $23.98 avg $27.85

Scenario Analysis

Bear Case

$18.55

-13.7%

Low target

Base Case

$23.98

+11.6%

Avg target

Bull Case

$27.85

+29.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$22.88

-6.1% from high

52-Week Low

$8.22

+161.4% from low

Target vs 52W High

$23.98

+4.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%